Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
Related discussions
-
her2 no hercipten (2 replies):I am 6 year breast cancer survivor with her2+. I had 4 ...[more]
Post Comment
Related Communities
Recent Videos
Related Expert Forums
Recent Activity
Most Popular Trackers
RSS
Expert Activity
Community Members
Popular Groups
From my searches, the FDA approval for femara was given on 2001 for hormone positive metastatic breast cancer. Presently, it is also indicated for adjuvant treatment for breast cancer (hormone positive also: ER/PR positive) for 5 years, even after 5 years of adjuvant tamoxifen. There is presently an ongoing clinical trial called BIG 1-98 which assesses several sequencing and duration of femara administration in the adjuvant setting. The preliminary results are out but the final results will not come out I think for another 1 or 2 years. Regards.